Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke

<div>Immunohistochemistry for GFP and GFAP. Panels show fluorescent photomicrographs around the brain surface where the RCP sponge contacted 5 weeks posttransplantation in the BMSC/scaffold groups. Green: GFP; red: GFAP. Scale bars: 100 <i>μ</i>m.</div>

Stem Cells International

fig7

Figure 7

Figure 7: Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke 